Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

G. Caocci; O. Mulas; I. Capodanno; E. Abruzzese; A. Iurlo; L. Luciano; F. Albano; M. Annunziata; M. Tiribelli; M. Bonifacio; S. Galimberti; F. Castagnetti; N. Sgherza; F. Stagno; A. Gozzini; E.M. Orlandi; D. Luzi; G. Binotto; P. Pregno; C. Fozza; F. Efficace; M.P. Simula; M.M. Trawinska; D. Cattaneo; F. De Gregorio; I. Attolico; R. Stella; L. Scaffidi; C. Baratè; G. Gugliotta; E. Scalzulli; C. Elena; F. Pirillo; R. Foà; M. Breccia; G.L. Nasa

doi:10.1038/s41408-020-0333-2

Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

G. Caocci, O. Mulas, I. Capodanno, E. Abruzzese, A. Iurlo, L. Luciano, F. Albano, M. Annunziata, M. Tiribelli, M. Bonifacio, S. Galimberti, F. Castagnetti, N. Sgherza, F. Stagno, A. Gozzini, E.M. Orlandi, D. Luzi, G. Binotto, P. Pregno, C. FozzaF. Efficace, M.P. Simula, M.M. Trawinska, D. Cattaneo, F. De Gregorio, I. Attolico, R. Stella, L. Scaffidi, C. Baratè, G. Gugliotta, E. Scalzulli, C. Elena, F. Pirillo, R. Foà, M. Breccia, G.L. Nasa

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Blood Cancer J.
Volume	10
Issue number	6
DOIs	https://doi.org/10.1038/s41408-020-0333-2
Publication status	Published - 2020

Keywords

cholesterol
high density lipoprotein
low density lipoprotein
ponatinib
triacylglycerol
adult
aged
artery occlusion
Article
cholesterol blood level
chronic myeloid leukemia
cohort analysis
drug withdrawal
dyslipidemia
female
human
Italian (citizen)
lipoprotein blood level
major clinical study
male
prognosis
risk reduction
triacylglycerol blood level

Access to Document

10.1038/s41408-020-0333-2

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086158202&doi=10.1038%2fs41408-020-0333-2&partnerID=40&md5=15ca169486f07f9c73f0fa3eff1942e3

Cite this

Caocci, G., Mulas, O., Capodanno, I., Abruzzese, E., Iurlo, A., Luciano, L., Albano, F., Annunziata, M., Tiribelli, M., Bonifacio, M., Galimberti, S., Castagnetti, F., Sgherza, N., Stagno, F., Gozzini, A., Orlandi, E. M., Luzi, D., Binotto, G., Pregno, P., ... Nasa, G. L. (2020). Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. Blood Cancer J., 10(6). https://doi.org/10.1038/s41408-020-0333-2

Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. / Caocci, G.; Mulas, O.; Capodanno, I.; Abruzzese, E.; Iurlo, A.; Luciano, L.; Albano, F.; Annunziata, M.; Tiribelli, M.; Bonifacio, M.; Galimberti, S.; Castagnetti, F.; Sgherza, N.; Stagno, F.; Gozzini, A.; Orlandi, E.M.; Luzi, D.; Binotto, G.; Pregno, P.; Fozza, C.; Efficace, F.; Simula, M.P.; Trawinska, M.M.; Cattaneo, D.; De Gregorio, F.; Attolico, I.; Stella, R.; Scaffidi, L.; Baratè, C.; Gugliotta, G.; Scalzulli, E.; Elena, C.; Pirillo, F.; Foà, R.; Breccia, M.; Nasa, G.L.

In: Blood Cancer J., Vol. 10, No. 6, 2020.

Research output: Contribution to journal › Article › peer-review

Caocci, G, Mulas, O, Capodanno, I, Abruzzese, E, Iurlo, A, Luciano, L, Albano, F, Annunziata, M, Tiribelli, M, Bonifacio, M, Galimberti, S, Castagnetti, F, Sgherza, N, Stagno, F, Gozzini, A, Orlandi, EM, Luzi, D, Binotto, G, Pregno, P, Fozza, C, Efficace, F, Simula, MP, Trawinska, MM, Cattaneo, D, De Gregorio, F, Attolico, I, Stella, R, Scaffidi, L, Baratè, C, Gugliotta, G, Scalzulli, E, Elena, C, Pirillo, F, Foà, R, Breccia, M & Nasa, GL 2020, 'Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study', Blood Cancer J., vol. 10, no. 6. https://doi.org/10.1038/s41408-020-0333-2

Caocci G, Mulas O, Capodanno I, Abruzzese E, Iurlo A, Luciano L et al. Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. Blood Cancer J. 2020;10(6). https://doi.org/10.1038/s41408-020-0333-2

Caocci, G. ; Mulas, O. ; Capodanno, I. ; Abruzzese, E. ; Iurlo, A. ; Luciano, L. ; Albano, F. ; Annunziata, M. ; Tiribelli, M. ; Bonifacio, M. ; Galimberti, S. ; Castagnetti, F. ; Sgherza, N. ; Stagno, F. ; Gozzini, A. ; Orlandi, E.M. ; Luzi, D. ; Binotto, G. ; Pregno, P. ; Fozza, C. ; Efficace, F. ; Simula, M.P. ; Trawinska, M.M. ; Cattaneo, D. ; De Gregorio, F. ; Attolico, I. ; Stella, R. ; Scaffidi, L. ; Baratè, C. ; Gugliotta, G. ; Scalzulli, E. ; Elena, C. ; Pirillo, F. ; Foà, R. ; Breccia, M. ; Nasa, G.L. / Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. In: Blood Cancer J. 2020 ; Vol. 10, No. 6.

@article{99d30c38d51c49129ec0dde447c7d1e8,

title = "Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study",

keywords = "cholesterol, high density lipoprotein, low density lipoprotein, ponatinib, triacylglycerol, adult, aged, artery occlusion, Article, cholesterol blood level, chronic myeloid leukemia, cohort analysis, drug withdrawal, dyslipidemia, female, human, Italian (citizen), lipoprotein blood level, major clinical study, male, prognosis, risk reduction, triacylglycerol blood level",

author = "G. Caocci and O. Mulas and I. Capodanno and E. Abruzzese and A. Iurlo and L. Luciano and F. Albano and M. Annunziata and M. Tiribelli and M. Bonifacio and S. Galimberti and F. Castagnetti and N. Sgherza and F. Stagno and A. Gozzini and E.M. Orlandi and D. Luzi and G. Binotto and P. Pregno and C. Fozza and F. Efficace and M.P. Simula and M.M. Trawinska and D. Cattaneo and {De Gregorio}, F. and I. Attolico and R. Stella and L. Scaffidi and C. Barat{\`e} and G. Gugliotta and E. Scalzulli and C. Elena and F. Pirillo and R. Fo{\`a} and M. Breccia and G.L. Nasa",

note = "Export Date: 26 February 2021 Correspondence Address: Caocci, G.; Hematology Unit, Italy; email: giovanni.caocci@unica.it",

year = "2020",

doi = "10.1038/s41408-020-0333-2",

language = "English",

volume = "10",

journal = "Blood Cancer J.",

issn = "2044-5385",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

AU - Caocci, G.

AU - Mulas, O.

AU - Capodanno, I.

AU - Abruzzese, E.

AU - Iurlo, A.

AU - Luciano, L.

AU - Albano, F.

AU - Annunziata, M.

AU - Tiribelli, M.

AU - Bonifacio, M.

AU - Galimberti, S.

AU - Castagnetti, F.

AU - Sgherza, N.

AU - Stagno, F.

AU - Gozzini, A.

AU - Orlandi, E.M.

AU - Luzi, D.

AU - Binotto, G.

AU - Pregno, P.

AU - Fozza, C.

AU - Efficace, F.

AU - Simula, M.P.

AU - Trawinska, M.M.

AU - Cattaneo, D.

AU - De Gregorio, F.

AU - Attolico, I.

AU - Stella, R.

AU - Scaffidi, L.

AU - Baratè, C.

AU - Gugliotta, G.

AU - Scalzulli, E.

AU - Elena, C.

AU - Pirillo, F.

AU - Foà, R.

AU - Breccia, M.

AU - Nasa, G.L.

N1 - Export Date: 26 February 2021 Correspondence Address: Caocci, G.; Hematology Unit, Italy; email: giovanni.caocci@unica.it

PY - 2020

Y1 - 2020

KW - cholesterol

KW - high density lipoprotein

KW - low density lipoprotein

KW - ponatinib

KW - triacylglycerol

KW - adult

KW - aged

KW - artery occlusion

KW - Article

KW - cholesterol blood level

KW - chronic myeloid leukemia

KW - cohort analysis

KW - drug withdrawal

KW - dyslipidemia

KW - female

KW - human

KW - Italian (citizen)

KW - lipoprotein blood level

KW - major clinical study

KW - male

KW - prognosis

KW - risk reduction

KW - triacylglycerol blood level

U2 - 10.1038/s41408-020-0333-2

DO - 10.1038/s41408-020-0333-2

M3 - Article

VL - 10

JO - Blood Cancer J.

JF - Blood Cancer J.

SN - 2044-5385

IS - 6

ER -